3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments.

Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs. […]
Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest.
Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population […]
Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic.
At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was […]
Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression.
In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes […]
How to Boost Patient Engagement for Cervical Cancer Clinical Trials
For Cervical Cancer Awareness Month, we examine how adopting a patient-centric approach can improve clinical trial experiences for cervical cancer patients.
How Sponsors and CROs Can Build Patient Trust in Clinical Trials
By prioritizing informational content and embracing social media, sponsors and CROs can build lasting connections with patients.
Report: Receiving Clinical Trial Results Makes Patients More Likely to Participate
A recent study reveals that sharing clinical trial results with patients can help boost trial participation and engagement.
4 Patient-Centric Clinical Trial Trends for 2019
2019 is the year of the patient. Here’s how CROs and sponsors can tap into patient-centric models to improve trial recruitment and retention.
How eConsent Is Changing Clinical Trials
With increased convenience and a more streamlined flow of information, eConsent offers benefits for patients and clinical trial investigator sites alike.